The Short Answer
Yes. Hereditary TTR-amyloidosis (1 in 100,000 people) causes polyneuropathy and is now treatable with vutrisiran, an FDA-approved gene silencer. Autoimmune neuropathy (Sjögren syndrome, lupus, vasculitis) accounts for ~5–10% of cases and requires immunosuppression or IVIG [2][4].
Hereditary TTR-amyloidosis is a genetic disorder where a mutated TTR protein clumps in your nerves and organs. It's rare but devastating: if inherited, polyneuropathy usually starts in your 50s–60s and progresses over 10–15 years. Vutrisiran, an IV infusion given every 3 months, silences the bad TTR gene and actually stops or reverses nerve damage in 50–65% of patients within 24 weeks [4].
If your mother, father, or sibling has early-onset neuropathy (before age 50), ask your doctor about genetic testing for TTR, Charcot-Marie-Tooth (CMT) genes, or other hereditary forms. A simple blood test confirms it. If positive, vutrisiran access requires a specialist neurologist, but Medicare covers 100% after deductible (~$0 copay), making it available regardless of income [4].
Autoimmune polyneuropathy (Sjögren syndrome, lupus, vasculitis, CIDP) causes 5–10% of cases. These require different treatment: IV immunoglobulin (IVIG) or corticosteroids to calm the immune attack. If you have dry eyes, dry mouth, joint pain, or a prior autoimmune diagnosis, mention it—testing with blood work (ANA, anti-SSA/SSB, complement levels) and nerve biopsy can confirm it [2].
Try This Today
If you have a family member with early neuropathy, ask them whether they ever got genetic testing. If yes, get tested yourself (TTR mutation, CMT genes). If no, request it at your next visit. Knowing your diagnosis unlocks targeted treatments that don't exist for other types.